Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) centers
Alzheimer's & Dementia · 2026-11 · 22 (11)
DOI: 10.1002/alz.71962 ↗Kurz gefasst
Editorial in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.11.2026. Verfasst von Allan I Levey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Goizueta Brain Health Institute and Alzheimer's Disease Research Center, Emory University, Atlanta, Georgia, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Goizueta Brain Health Institute and Alzheimer's Disease Research Center, Emory University, Atlanta, Georgia, USA.
- Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Indiana Biosciences Research Institute, Indianapolis, Indiana, USA.
ORCID-Profile: Allan I Levey
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Levey, A. I., & Palkowitz, A. D. (2026). Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) centers. Alzheimer's & Dementia, 22(11). https://doi.org/10.1002/alz.71962
Vancouver
Levey AI, Palkowitz AD. Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) centers. Alzheimer's & Dementia. 2026;22(11). doi:10.1002/alz.71962
BibTeX
@article{Levey2026,
author = {Levey, Allan I and Palkowitz, Alan D},
title = {Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) centers},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {11},
doi = {10.1002/alz.71962}
}
EUVIMED